
FStar Therapeutics Earnings miss, Revenue beats In Q3
Investing.com - FStar Therapeutics reported on Tuesday third quarter {{erl-977678||earnings that missed analysts' forecasts and revenue that topped expectations. FStar Therapeutics...
Investing.com - FStar Therapeutics reported on Tuesday third quarter {{erl-977678||earnings that missed analysts' forecasts and revenue that topped expectations. FStar Therapeutics...
F-star Therapeutics, Inc. (FSTX) reported Q2 EPS of ($0.88), $0.29 worse than the analyst estimate of ($0.59).
Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Healthcare, Utilities and Telecoms sectors propelled shares higher. At the close in NYSE, the Dow Jones...
Pre-Open Stock Movers:F-star Therapeutics, Inc. (FSTX) 67% HIGHER; invoX Pharma (invoX), a wholly owned subsidiary of Sino Biopharmaceutical Limited, will acquire all of the issued and...
Investing.com – U.S. equities were higher at the close on Monday, as gains in the Oil & Gas, Financials and Industrials sectors propelled shares higher. At the close in NYSE, the Dow Jones...
Investing.com – U.S. equities were lower at the close on Tuesday, as losses in the Basic Materials, Oil & Gas and Technology sectors propelled shares lower. At the close in NYSE, the Dow...
Investing.com – U.S. equities were mixed at the close on Wednesday, as gains in the Basic Materials, Technology and Utilities sectors propelled shares higher while losses in the Telecoms,...
Investing.com – U.S. equities were higher at the close on Thursday, as gains in the Consumer Services, Technology and Financials sectors propelled shares higher. At the close in NYSE, the...
Investing.com – U.S. equities were higher at the close on Monday, as gains in the Healthcare, Technology and Financials sectors propelled shares higher. At the close in NYSE, the Dow Jones...
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.